TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pfizer AB
Closing information (x1000 NOK)
| Closing information | 2024/11 | 2023/11 | 2022/11 |
| Turnover |
1,973,272
|
2,199,822
|
3,964,930 |
| Financial expenses |
3,033
|
1,839
|
3,058 |
| Earnings before taxes |
65,180
|
120,108
|
41,668 |
| EBITDA |
66,111
|
118,515
|
212,961 |
| Total assets |
1,206,891
|
1,102,809
|
1,716,508 |
| Current assets |
1,185,118
|
1,073,084
|
1,694,512 |
| Current liabilities |
771,182
|
621,307
|
1,357,561 |
| Equity capital |
435,709
|
481,501
|
358,946 |
| - share capital |
36,210
|
36,612
|
33,800 |
| Employees (average) |
158
|
155
|
145 |
Financial ratios
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Solvency |
36.1%
|
43.7%
|
20.9% |
| Turnover per employee |
12,489
|
14,192
|
27,344 |
| Profit as a percentage of turnover |
3.3%
|
5.5%
|
1.1% |
| Return on assets (ROA) |
5.7%
|
11.1%
|
2.6% |
| Current ratio |
153.7%
|
172.7%
|
124.8% |
| Return on equity (ROE) |
15.0%
|
24.9%
|
11.6% |
| Change turnover |
-202,426
|
-2,094,921
|
3,330,404 |
| Change turnover % |
-9%
|
-49%
|
525% |
| Chg. No. of employees |
3
|
10
|
62 |
| Chg. No. of employees % |
2%
|
7%
|
75% |
Total value of public sale
| Fiscal year | 2024/11 | 2023/11 | 2022/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.